hours the broth was fed with 60mg ofI, 13-ep/-selamectin aglycone, dissolved in a minimumvolume of methanol and the fermentation harvested at 144 hours.
describe here the preparation, through biotransformation, of 13-e/?/-selamectin using a blocked mutant of S. avermitilis, 15-63, as part of our investigation into the SARof flea activity with this class of compounds.
A loopful of the S. avermitilis culture 15-63 which is stored on 1/4 strength ATCC172agar was inoculated into two 300ml Erlenmeyer shake-flasks containing 50ml of AS-7 inoculum mediumcomprising Nadex®starch 2.0%, Pharmamedia® cotton seed meal 1.5%, Ardamine® nitrogen source 0.5% and CaCO3 0.2% adjusted to pH 7.2 with 1 m NaOHsolution. After 48 hours incubation at 28°C on a rotary shaker at 200rpm, these flasks were used to inoculate 3.5 litres of AP-5 medium in a 5 litre mini-jar (Electrolab, Gloucester, U.K. GL20 7LR hours the broth was fed with 60mg ofI, 13-ep/-selamectin aglycone, dissolved in a minimumvolume of methanol and the fermentation harvested at 144 hours.
The culture broth from the mini-jar was extracted with ethyl acetate (5 litres) and then the solvent layer concentrated to gum solid (4.2g). The extract was then dissolved in methylene chloride and applied to a column of when fed with the 13-gpz-selamectin aglycone I. The epimerisation is described elsewhere.4) (Fig. 1) Following the addition of I to this organism all the starting material disappeared and three bioconversion products appeared, unexpectedly the major of which was the 13-£p/-a-oleandrosyl analogue of selamectin, II (
2). The presence of this monosaccharide is intriguing, as previous studies have shown that with naturally derived avermectin aglycones, which are the natural substrates for these glycosidation enzymes, the sole products whenfed to this organism are disaccharides.5) Significant changes in chemical shift of the surrounding protons suggested that II had a different stereochemistry at the 13 position frorr selamectin. Thus the ll-, 12-, 13-and 15-protons and the 5'-and 12-methyl protons all had chemical shifts altered b> up to 0.46ppm compared with those found in selamectin, (see Table 1 ). The assignments of these protons were confirmed by inspection of the 2-dimensional proton NMR (COSY) ofII (Fig. 4) . The 12-proton signal can clearly be seen to couple with the ll and 13 protons and the 12-methyl group. The 13-proton signal was not sufficiently resolved at either 300 or 500 MHzto allow determination of the coupling constant with the 12-proton. However, in the NMRspectrum of II it had moved upfleld by at least 0.46ppm and could not be resolved from a number of protons which were attached to carbons adjacent to oxygen. TSP-MSdata gave the expected molecular ion mlz 111 ([M+H+]) for II which is the same as that for selamectin. HPLCassay3) gave a retention time of22.4 for II and 23.0 minutesfor selamectin. unsubstituted milbemycin LLF-28249a7) were also fed to S. avermitilis 15-63 using the same protocol described above. Again the major biotransformation product was the corresponding ( 1 3i?)-a-oleandrosyl-milbemycin IV and the minor products were identified as the 3 '-O-demethyl-(13^)-a-oleandrosyl milbemycin V and the disaccharide, (13i?)-a-oleandrosyl-a-oleandrosyl milbemycin VI. (Fig.  3) VI was also formed by re-feeding the monosaccharide IV to the fermentation, indicating that IV is an intermediate in the formation ofVI.
All products showed at least 10X reduced activity in a flea in vitro assay compared with selamectin.
